Acceptance of COVID-19 Booster Dose 3 Based on the Health Belief Model: A Study at Peureulak Public Health Center
DOI:
https://doi.org/10.12928/dpphj.v19i1.12696Keywords:
Covid-19, Vaccine perception, Health belief model, Covid-19 boosterAbstract
Background: The COVID-19 vaccination program faces significant challenges due to public hesitation, with some individuals rejecting or harboring doubts across the 34 provinces of Indonesia. The Health Belief Model, one of the most widely used theories for understanding health and illness behaviors, provides a framework for examining participants' perceptions of susceptibility, severity, benefits, barriers, self-efficacy, and cues to action regarding COVID-19 vaccination. This study aimed to assess the acceptance of the third dose of the COVID-19 vaccine (Booster) using the Health Belief Model at Peureulak Public Health Center, East Aceh. Method: This research was conducted at the Peureulak Health Center, East Aceh. and employed an analytical quantitative approach with a cross-sectional design, involving 394 participants selected through purposive sampling. Data analysis methods applied include univariate, bivariate, and multivariate. Result: Results showed a significant association between perceived susceptibility and vaccine acceptance, particularly concerning infection risk. However, no significant relationship was identified between perceived severity and acceptance. Perceived benefits, in the terms of the belief that vaccination could reduce the risk of infection or complications and alleviate concerns about COVID-19 were strongly associated with vaccine acceptance. Perceived barriers were also significantly related to vaccine acceptance, especially regarding concerns over potential side effects. Additionally, cues to action, such as adequate information about COVID-19 and vaccination, positively contributed to increased vaccine acceptance. Conclusion: perceived susceptibility, perceived benefits, perceived barriers, and cues to action were significantly related to vaccine acceptance.
References
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157–60. https://doi.org/10.23750/abm.v91i1.9397.
John Hopkins University Coronavirus Resource Center. COVID-19 Map. Coronavirus Resour Center, John Hopkins Univ 2023. https://coronavirus.jhu.edu/map.html.
Rismanbaf A. Potential Treatments for COVID-19; a Narrative Literature Review. Arch Acad Emerg Med 2020;8:e29. https://doi.org/10.22037/aaem.v8i1.596.
Food and Drug Administration. FDA Approves First COVID-19 Vaccine Approval Signifies Key Achievement for Public Health. FDA 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
Kasworo P. Presiden Jokowi Menerima Vaksin Covid-19 Perdana. Pres RI n.d. https://www.presidenri.go.id/siaran-pers/presiden-jokowi-menerima-vaksin-covid-19-perdana/.
Indonesian Ministry of Health. Profil Kesehatan Indonesia 2022. Jakarta: 2023.
Timur WRC-19 KA. Update Laporan Data Vaksinasi Covid-19 di Kabupaten Aceh Timur Tanggal 6 April 2022. Website Resmi COVID-19 Kabupaten Aceh Timur 2022. https://covid19.acehtimurkab.go.id/berita/kategori/info-update-covid19-aceh-timur/update-laporan-data-vaksinasi-covid-19-di-kabupaten-aceh-timur-tanggal-6-april-2022.
Indonesian Ministry of Health, ITAGI, UNICEF, WHO. Joint Press Release - Survei Penerimaan Vaksin COVID-19 2020. https://www.who.int/indonesia/news/detail/17-11-2020-joint-press-release---survei-penerimaan-vaksin-covid-19.
WHO. Strategic Advisory Group of Experts on Immunization (SAGE). WHO 2021. https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization.
WHO. Ten health issues WHO will tackle this year. WHO 2020. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
Salsabila Z, Syahrul F. Faktor yang Berhubungan dengan Keikutsertaan Masyarakat dalam Vaksinasi Covid-19 : Literature Review. Media Publ Promosi Kesehat Indones 2023;6:27–36. https://doi.org/10.56338/mppki.v6i1.2882.
Asihaer Y, Sun M, Li M, Xiao H, Amaerjiang N, Guan M, et al. Predictors of Influenza Vaccination among Chinese Middle School Students Based on the Health Belief Model: A Mixed-Methods Study. Vaccines 2022;10. https://doi.org/10.3390/vaccines10111802.
Trent MJ, Salmon DA, MacIntyre CR. Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019. Influenza Other Respi Viruses 2021;15:678–87. https://doi.org/10.1111/irv.12843.
Zambri F, Quattrini A, Perilli I, Alegiani SS, Marchetti F, Colaceci S, et al. Health Belief Model efficacy in explaining and predicting intention or uptake influenza vaccination during pregnancy. Ann Ist Super Sanita 2022;58:285–92. https://doi.org/10.4415/ANN_22_04_09.
Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother 2020;16:2204–14. https://doi.org/10.1080/21645515.2020.1790279.
Limbu YB, Gautam RK, Pham L. The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines 2022;10. https://doi.org/10.3390/vaccines10060973.
Dinas Kesehatan Kabupaten Aceh Timur. Profil Kesehatan Aceh Timur. Aceh Timur: 2021.
Antoro B. Analisis Penerapan Formula Slovin dalam Penelitian Ilmiah: Kelebihan, Kelemahan, dan Kesalahan dalam Perspektif Statistik. J Multidisiplin Sos Dan Hum 2024;1:53–63. https://doi.org/10.70585/JMSH.V1I2.38.
Sugiyono. Metode Penelitian Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta; 2018.
McHugh ML. The Chi-square test of independence. Biochem Medica 2013;23:143–9. https://doi.org/10.11613/BM.2013.018.
Ghazy RM, Abdou MS, Awaidy S, Sallam M, Elbarazi I, Youssef N, et al. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Int J Environ Res Public Health 2022;19. https://doi.org/10.3390/ijerph191912136.
Tribratanews POLDA Aceh. Polda Aceh Masih Gelar Vaksinasi Covid-19. Tribratanews POLDA Aceh 2023. https://tribratanews.aceh.polri.go.id/polda-aceh-masih-gelar-vaksinasi-covid-19/.
Hu S, Xiong R, Hu Q, Li Q. Effects of Nursing Intervention Based on Health Belief Model on Self-Perceived Burden, Drug Compliance, and Quality of Life of Renal Transplant Recipients. Contrast Media Mol Imaging 2022;2022. https://doi.org/10.1155/2022/3001780.
Arsyi DAP. Persepsi dan Penerimaan Vaksin Booster Covid-19 pada Masyarakat Provinsi Daerah Istimewa Yogyakarta. Universitas Gadjah Mada, 2022.
Tarmizi SN. Segera Booster Vaksinasi COVID-19 untuk Kurangi Risiko Kematian. Sehat Negeriku Sehatlah Bangsaku, Kementeri Kesehat Republik Indones 2022. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20221109/0141625/segera-booster-vaksinasi-covid-19-untuk-kurangi-risiko-kematian/.
Mohsin SF, Agwan MA, Shaikh S, Alsuwaydani ZA, AlSuwaydani SA. COVID-19: Fear and Anxiety among Healthcare Workers in Saudi Arabia. A Cross-Sectional Study. Inq (United States) 2021;58. https://doi.org/10.1177/00469580211025225.
Hita MLR, Grégoire Y, Lussier B, Boissonneault S, Vandenberghe C, Sénécal S. An extended health belief model for COVID-19: understanding the media-based processes leading to social distancing and panic buying. J Acad Mark Sci 2023;51:132–52. https://doi.org/10.1007/S11747-022-00865-8/FIGURES/5.
Quadros S, Garg S, Ranjan R, Vijayasarathi G, Mamun MA. Fear of COVID 19 Infection Across Different Cohorts: A Scoping Review. Front Psychiatry 2021;12. https://doi.org/10.3389/fpsyt.2021.708430.
Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, et al. Public perceptions and acceptance of covid-19 booster vaccination in china: A cross-sectional study. Vaccines 2021;9. https://doi.org/10.3390/vaccines9121461.
Abuhammad S, Khabour OF, Alzoubi KH, Hamaideh S, Alzoubi BA, Telfah WS, et al. The public’s attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan. PLoS One 2022;17. https://doi.org/10.1371/journal.pone.0271625.
Bălan A, Bejan I, Bonciu S, Eni CE, Ruță S. Romanian medical students’ attitude towards and perceived knowledge on covid-19 vaccination. Vaccines 2021;9. https://doi.org/10.3390/vaccines9080854.
Al-Qerem W, Bawab AQ Al, Hammad A, Ling J, Alasmari F. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study. Vaccines 2022;10. https://doi.org/10.3390/vaccines10030410.
Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021;398:2093–100. https://doi.org/10.1016/S0140-6736(21)02249-2.
Babicki M, Malchrzak W, Hans-Wytrychowska A, Mastalerz-Migas A. Impact of vaccination on the sense of security, the anxiety of COVID-19 and quality of life among Polish. A nationwide online survey in Poland. Vaccines 2021;9. https://doi.org/10.3390/vaccines9121444.
Mallah N, Pardo-Seco J, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, et al. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain. Environ Res 2022;215. https://doi.org/10.1016/j.envres.2022.114252.
Rosiello DF, Anwar S, Yufika A, Adam RY, Ismaeil MI, Ismail AY, et al. Acceptance of covid-19 vaccination at different hypothetical efficacy and safety levels in ten countries in asia, africa, and south america. Narra J 2021;1. https://doi.org/10.52225/narra.v1i3.55.
Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, et al. High rates of covid-19 vaccine hesitancy and its association with conspiracy beliefs: A study in jordan and kuwait among other arab countries. Vaccines 2021;9:1–16. https://doi.org/10.3390/vaccines9010042.
Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. The perception and attitudes toward covid-19 vaccines: A cross-sectional study in poland. Vaccines 2021;9. https://doi.org/10.3390/vaccines9040382.
Moreira ED, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, et al. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine. N Engl J Med 2022;386:1910–21. https://doi.org/10.1056/nejmoa2200674.
KOMDIGI. Presiden tegaskan vaksinasi dosis ketiga gratis. Indones Minist Commun Digit Aff 2022. https://www.komdigi.go.id/berita/berita-pemerintahan/detail/presiden-tegaskan-vaksinasi-dosis-ketiga-gratis.
Indonesian Ministry of Health. Vaksinasi COVID-19 Nasional 2022. https://vaksin.kemkes.go.id/#/vaccines.
Sudarsono H, Ikawati R, Azizah SN, Kurnia A, Nuanmark P. Does “Halalness” Affect Young Muslims’ Intentions to Use the COVID-19 Vaccine? Indones J Halal Res 2023;5:30–40. https://doi.org/10.15575/ijhar.v5i1.19248.
Alobaidi S, Hashim A. Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey. Vaccines 2022;10. https://doi.org/10.3390/vaccines10070987.
Alibrahim J, Awad A. COVID-19 vaccine hesitancy among the public in Kuwait: A cross-sectional survey. Int J Environ Res Public Health 2021;18. https://doi.org/10.3390/ijerph18168836.
MacDonald NE, Butler R, Dubé E. Addressing barriers to vaccine acceptance: an overview. Hum Vaccines Immunother 2018;14:218–24. https://doi.org/10.1080/21645515.2017.1394533.
Rahayu RN, Sensusiyati. Vaksin COVID 19 di Indonesia: Analisis Berita Hoax. J Ekon Sos Hum 2021;2:39–49.
KOMDIGI. [Hoaks] Banyak Data Orang Meninggal Karena Vaksin Covid-19. Indones Minist Commun Digit Aff 2021. https://www.komdigi.go.id/berita/pengumuman/detail/hoaks-banyak-data-orang-meninggal-karena-vaksin-covid-19.
Bennett NG, Bloom DE, Ferranna M. Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption. PLoS One 2022;17. https://doi.org/10.1371/journal.pone.0274529.
Al-Metwali BZ, Al-Jumaili AA, Al-Alag ZA, Sorofman B. Exploring the acceptance of COVID-19 vaccine among healthcare workers and general population using health belief model. J Eval Clin Pract 2021;27:1112–22. https://doi.org/10.1111/jep.13581.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Universitas Ahmad Dahlan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors transfer the copyright and grant the Disease Prevention and Public Health Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Disease Prevention and Public Health Journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Disease Prevention and Public Health Journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
